Database | Recombinant Antibodies And Mimetics Database

What can we help you find?

You are searching for:

Category A

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category B

Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation

Category C

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category D

Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category E

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category F

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with animal-derived biomaterials used in production or final formulation

Category G

Original source/host: Unknown
Discovery method: Unknown
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Uncategorised Antibodies

Uncategorised Antibodies have Antibody/Binder Origins set in such a way as to prevent them from being assigned to a valid Antibody Category.

Click here to view all Antibody Category descriptions and to search directly by Antibody Category

Category A
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category B
- Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
- Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
- Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
Search
Category C
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category D
- Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category E
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category F
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
Search
Category G
- Original source/host: Unknown
- Discovery method: Unknown
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search

77931-77940 of 78246 results

Catalogue Number:

orb688997

Category:

TRAF2 antibody

Target:	TRAF2
Target Alias Names:	TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3), TRAF2, TRAP3
Species Reactivity:	Human
Applications:	ELISA, Flow Cytometry, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	Rabbit IgG
Host Species:	Rabbit
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1126

Category:

Tralokinumab Biosimilar – Anti-IL13 mAb – Research Grade

Target:	IL13
Target Alias Name:	Tralokinumab/CAT-354/IL13/anti-IL13
Species Reactivity:	Human
Type:	Primary Recombinant
Isotype/Mimetic:	IgG4-lambda
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

AMM09484V

Category:

Transferrin (TF) Mouse Monoclonal Antibody [Clone ID: LBI5G2]

Target:	TF
Species Reactivity:	Human
Applications:	Flow Cytometry, Immunofluorescence
Type:	Primary Recombinant
Host Species:	Mouse
Animal-Derived Biomaterials Used:	BSA, KLH, FCS, Other
Sequence Available	No
Original Discovery Methods	Animal-derived from single B cell, Animal-derived from hybridomas excluding ascites
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

AMM09524V

Category:

Transketolase (TKT) Mouse Monoclonal Antibody [Clone ID: LBI5H3]

Target:	TKT
Species Reactivity:	Human, Mouse, Rat
Applications:	Flow Cytometry, Immunofluorescence, Western Blot
Type:	Primary Recombinant
Host Species:	Mouse
Animal-Derived Biomaterials Used:	BSA, KLH, FCS, Other
Sequence Available	No
Original Discovery Methods	Animal-derived from single B cell, Animal-derived from hybridomas excluding ascites
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

orb689034

Category:

Transthyretin antibody

Target:	TTR
Target Alias Names:	Transthyretin (ATTR) (Prealbumin) (TBPA), TTR, PALB
Species Reactivity:	Human
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	Rabbit IgG
Host Species:	Rabbit
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb689060

Category:

Transthyretin antibody

Target:	TTR
Target Alias Names:	Transthyretin (ATTR) (Prealbumin) (TBPA), TTR, PALB
Species Reactivity:	Human
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	Rabbit IgG
Host Species:	Rabbit
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1005

Category:

Trastuzumab Biosimilar – Anti-HER2 mAb – Research Grade

Target:	HER2
Target Alias Name:	Trastuzumab/Trastuzumab/HER2/anti-HER2
Species Reactivity:	Human
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA2143

Category:

Traxivitug Biosimilar – Anti-Major capsid protein VP1 mAb – Research Grade

Target:	Major capsid protein VP1
Species Reactivity:	Human
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1-lambda2
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1263

Category:

Tregalizumab Biosimilar – Anti-CD4 mAb – Research Grade

Target:	CD4
Target Alias Name:	Tregalizumab/BT-061/ hB-F5/ hBF5(H37L_L4M)/CD4/anti-CD4
Species Reactivity:	Human
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1-kappa
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb1291198

Category:

TREM2 Antibody

Target:	TREM2
Target Alias Names:	PLOSL2, TREM-2, Trem2a, Trem2b, Trem2c
Species Reactivity:	Human
Applications:	ELISA, Flow Cytometry
Type:	Primary Recombinant
Isotype/Mimetic:	Rabbit/Human Fc chimeric IgG1
Host Species:	Rabbit
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Viewing 77931-77940 of 78246 results

Previous
1
…
7,793
7,794
7,795
…
7,825
Next

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.